Clinical trial
Open-Label Surufatinib in European Patients With NET
NCT04579679
Study timeline
Study start (actual)2021-08-13Date precision: day
Registry last updated2025-07-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neuroendocrine Tumoursunresolved
Neuroendocrine Tumour of the Lungunresolved
Small Intestinal NETunresolved
Interventions
SurufatinibDRUG
Sponsors & collaborators
Hutchmedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04579679 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.